Invibio's Dr. Fedra Zaribaf Secures Prestigious UKRI Future Leaders Fellowship
Invibio's Dr. Fedra Zaribaf Secures Prestigious UKRI Future Leaders Fellowship for Revolutionary Cartilage Repair Technology Research
Invibio proudly announces that Dr. Fedra Zaribaf, Strategic Technology Manager, has been awarded the prestigious UK Research and Innovation (UKRI) Future Leaders Fellowship. This accolade, a testament to Dr. Zaribaf's exceptional talent, underscores Invibio's commitment to advancing world-class research and innovation.
The fellowship places Dr. Zaribaf and Invibio at the forefront of a transformative initiative targeting a global concern affecting 1 in 4 adults: cartilage lesions. The ambitious project aims to revolutionize cartilage lesion repair on a global scale. Left untreated, these lesions can lead to severe clinical issues, impacting over 60% of patients undergoing total knee replacement.
In response to this critical issue, Dr. Zaribaf's fellowship will spearhead the development of a groundbreaking technology platform for cartilage lesion repair. Harnessing the proven properties of Invibio's PEEK-OPTIMA™, the project seeks to establish a platform technology for a highly effective treatment option. Addressing the current lack of clinically proven long-term outcomes for cartilage lesion treatments, this innovative project aims to fill that void.
The selection process for the UKRI Future Leaders Fellowships was exceptionally rigorous, with a notoriously low success rate. Dr. Zaribaf's project underwent meticulous evaluation, considering Research & Innovation Excellence, Applicant & their Development, Impact & Strategic Relevance, and Host Organization. This rigorous process, spanning a year, included the submission of a comprehensive project outline, application, and an interview with industry-based senior leaders.
Ian Revie, Head of Horizon 2 Programmes at Invibio comments, "We are incredibly proud of Dr. Zaribaf's accomplishment. At Invibio, our unparalleled expertise propels us forward, and we eagerly champion this pivotal research. Committed to pushing the boundaries of innovation, we hope to leverage our trusted PEEK-OPTIMA™ polymer with the ultimate goal of enhancing patient outcomes."
You may also be interested in...
12 October 2023
Victrex announces a new product grade launch, Victrex Pharmaceutical Contact (PC)101 (VICTREX PC™101)
From the invention of PEEK over 40 years ago, Victrex has continually pioneered new PAEK-based polymers, materials and solutions that have transformed markets, delivering global impact in the toughest environments.
We bring transformational & sustainable solutions that address world material challenges every day.